⌘K

Login Start Free

Home/Filings/4/0001104659-20-077512

4//SEC Filing

Yablonka Uri 4

Accession 0001104659-20-077512

CIK 0001137883other

View on SEC.gov Company Profile

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 5:00 PM ET

Size

4.9 KB

Accession

0001104659-20-077512

Insider Transaction Report

Form 4

Period: 2020-06-23

BRAINSTORM CELL THERAPEUTICS INC.BCLI

DirectorChief Operating Officer

Transactions

Award
Common Stock
2020-06-23+10,000→ 17,543 total

Documents

1 file

4
tm2023245d1_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

BRAINSTORM CELL THERAPEUTICS INC.

CIK 0001137883

Entity typeother

Related Parties

1

filerCIK 0001608814

Filing Metadata

Form type: 4
Filed: Jun 25, 8:00 PM ET
Accepted: Jun 26, 5:00 PM ET
Size: 4.9 KB

View on SEC.gov